BioMarin Pharmaceutical Inc (BMRN): Net Income
$348.90M
Year ended 2025-12-31
$72.97M
Trailing 12 months to 2026-06-30
+35.1%
3-year compound annual growth
-16.4%
5-year compound annual growth
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $348.90M | -18.3% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $426.86M | +154.6% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $167.65M | +18.4% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $141.56M | n/m | 2025-02-24, From 2022-01-01 |
| 2021-12-31 | -$64.08M | n/m | 2024-02-26, From 2021-01-01 |
| 2020-12-31 | $854.03M | n/m | 2023-02-27, From 2020-01-01 |
| 2019-12-31 | -$23.85M | n/m | 2022-02-25, From 2019-01-01 |
| 2018-12-31 | -$77.21M | n/m | 2021-02-26, From 2018-01-01 |
| 2017-12-31 | -$117.04M | n/m | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | -$630.21M | n/m | 2019-02-28, From 2016-01-01 |
| 2015-12-31 | -$171.80M | n/m | 2018-02-26, From 2015-01-01 |
| 2014-12-31 | -$133.97M | n/m | 2017-02-27, From 2014-01-01 |
| 2013-12-31 | -$176.35M | n/m | 2016-02-29, From 2013-01-01 |
| 2012-12-31 | -$114.35M | n/m | 2015-03-02, From 2012-01-01 |
| 2011-12-31 | -$53.84M | n/m | 2014-02-26, From 2011-01-01 |
| 2010-12-31 | $205.82M | n/m | 2013-02-26, From 2010-01-01 |
| 2009-12-31 | -$488.0K | n/m | 2012-02-22, From 2009-01-01 |
| 2008-12-31 | $30.83M | n/a | 2011-02-24, From 2008-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $348.90M | -18.3% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $1.33B | +11.7% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | $72.06M | n/m |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $313.75M | n/m |
| Perrigo Co PLC (PRGO) | 2025-12-31 | -$1.43B | n/m |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | -$356.15M | n/m |
| Royalty Pharma plc (RPRX) | 2025-12-31 | $770.95M | -10.2% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | -$232.00M | n/m |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | -$713.41M | n/m |
Compare BMRN, UTHR, AMRX, ALNY side by side · Screen every company in Pharmaceutical Preparations ↗